Enhancement of delayed cutaneous hypersensitivity by oral administration of RU 41740 (Biostim®) in lymphoma patients — A randomized double blind multicentric trial

Abstract RU 41740 (Biostim ® ) is a glycoprotein extract from Klebsiella pneumoniae with immunostimulating properties in animal studies and in in vitro assays of human leukocyte functions. The present randomized double blind phase II trial showed that RU 41740 significantly ( P